After hours: December 26 at 5:33:35 PM EST Loading Chart for VTRS ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

Viatris disclosed that its manufacturing facility in Indore, India, was issued a warning letter from the FDA, which banned 11 products that are produced at the site from being imported into the U ...

Global pharma major Viatris has been issued a warning letter and an alert barring import of a clutch of products from its oral finished dose manufacturing plant in Indore, Madhya Pradesh ...

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

(Reuters) -Viatris said on Monday the U.S. Food and Drug Administration has restricted imports of 11 products made at the drugmaker's facility in India after the regulator's inspection found it ...

Novartis and Viatris have become the latest pharma companies to be named in lawsuits claiming that they profited from the unlawful use of HeLa cells derived from cells taken from a cancer patient ...

The FDA has issued a warning letter to Viatris related to its drug manufacturing facility in Indore in the central Indian state of Madhya Pradesh, the company said, without disclosing the specifics of ...

St. Kitts And Nevis Committed To Raising National Standards In The Interest Of Quality And Public Safety, Assures Senior Minister Douglas December 20, 2024 ...

The FDA has issued a warning letter to Viatris related to its drug manufacturing facility in Indore in Madhya Pradesh, the company said, without disclosing the specifics of the warning.